Jan 09, 2019
A range of rare genetic disorders is pinpointed by a deep-learning algorithm. This helps doctors and researchers by analysing pictures of people’s faces. Researchers describe the technology after the diagnostic aid, a smartphone app called Face2Gene. It relies on machine-learning algorithmsand brain-like neural...
Read More...
Oct 09, 2018
FDA approves transthyretin amyloidosis therapy of Akcea, Ionis Patients with an orphan, hereditary disease that is transthyretin amyloidosis with a second new treatment option are available after the Food and Drug Administration approved Akcea Therapeutics and Ionis Pharmaceuticals' Tegsedi. As Tegsedi is approved,...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper